Fine Foods & Pharmaceuticals NTM SpA
F:9S5

Watchlist Manager
Fine Foods & Pharmaceuticals NTM SpA Logo
Fine Foods & Pharmaceuticals NTM SpA
F:9S5
Watchlist
Price: 8.42 EUR 1.2%
Market Cap: €185.7m

Wall St Price Targets

9S5 Price Targets Summary
Fine Foods & Pharmaceuticals NTM SpA

Wall Street analysts forecast 9S5 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 9S5 is 14.73 EUR with a low forecast of 13.4 EUR and a high forecast of 16.83 EUR.

Lowest Forecast
Price Target
13.4 EUR
59% Upside
Average Forecast
Price Target
14.73 EUR
75% Upside
Highest Forecast
Price Target
16.83 EUR
100% Upside
Fine Foods & Pharmaceuticals NTM SpA Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate for Revenue over the next 7 years is 11%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Fine Foods & Pharmaceuticals NTM SpA

Operating Income
Forecast

N/A
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

The compound annual growth rate for Operating Income over the next 7 years is 15%.

Pre-Tax Income
Forecast

N/A
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 29%.

Net Income
Forecast

N/A
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

The compound annual growth rate for Net Income over the next 3 years is 28%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 9S5's stock price target?
Price Target
14.73 EUR

According to Wall Street analysts, the average 1-year price target for 9S5 is 14.73 EUR with a low forecast of 13.4 EUR and a high forecast of 16.83 EUR.

What is the Revenue forecast for Fine Foods & Pharmaceuticals NTM SpA?
Projected CAGR
11%

The compound annual growth rate for Revenue over the next 7 years is 11%.

What is the Operating Income forecast for Fine Foods & Pharmaceuticals NTM SpA?
Projected CAGR
15%

The compound annual growth rate for Operating Income over the next 7 years is 15%.

What is the Pre-Tax Income forecast for Fine Foods & Pharmaceuticals NTM SpA?
Projected CAGR
29%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 29%.

What is the Net Income forecast for Fine Foods & Pharmaceuticals NTM SpA?
Projected CAGR
28%

The compound annual growth rate for Net Income over the next 3 years is 28%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett